Catalyst Wire Dossier Catalyst Wire Dossier

Bomedemstat

bomedemstat · Imago BioSciences, Inc.
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Bomedemstat, covering 2023-05-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006) [Phase 3]

See pricing